ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares
November 18, 2024
05 Nov 2021

Acarix decides on a fully guaranteed rights issue of approximately SEK 79,3 million to expand on the US market

Press release (MAR) Malmö, Sweden, November 5, 2021 Acarix decides on a fully guaranteed rights issue of approximately SEK 79,3 ...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, MAR, News, Regulatory, Shares, Swedish
November 18, 2024
05 Nov 2021

Acarix beslutar om en fullt garanterad företrädesemission om cirka 79,3 MSEK för att expandera på USA-marknaden

Pressrelease (MAR) Malmö, 5 november, 2021 Acarix beslutar om en fullt garanterad företrädesemission om cirka 79,3 MSE...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
27 Oct 2021

Acarix granted US CPT reimbursement code for CADScor System

Press release (MAR)Malmö, Sweden, October 27, 2021 Acarix granted US CPT reimbursement code for CADScor System The editorial pan...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Staff change
November 18, 2024
28 Sep 2021

ACARIX begins US expansion and appoints Helen Ljungdahl Round as President Acarix Inc

Press releaseNew York, USA, September 28, 2021 ACARIX begins US expansion and appoints Helen Ljungdahl Round as President Acarix Inc ...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Staff change, Swedish
November 18, 2024
14 Sep 2021

Acarix inleder USA expansion och utser USA-chef

        PressmeddelandeMalmö, 14 september 2021 Acarix inleder USA expansion och uts...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Staff change
November 18, 2024
14 Sep 2021

Acarix begins US expansion and appoints US President

        Press releaseMalmö, Sweden, September 14, 2021 Acarix begins US expansion and app...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
07 Sep 2021

New health economic study proves the value of CADScor® in coronary disease diagnostics

        Press releaseMalmö, Sweden, September 7, 2021 New health economic study proves th...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
07 Sep 2021

Ny sjukvårdsekonomisk studie lägger fram bevis för värdet av CADScor® vid diagnostik av kranskärlssjukdom

        PressmeddelandeMalmö, 7 september 2021 Ny sjukvårdsekonomisk studie l&...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
27 Aug 2021

Initial Dan-NICAD II results presented today at ESC

         Press releaseMalmö, Sweden, August 27, 2021 Initial Dan-NICAD II results pres...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
27 Aug 2021

Första resultaten från Dan-NICAD II presenteras idag på ESC

         PressmeddelandeMalmö den 27 augusti 2021 Första resultaten från Da...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
23 Aug 2021

Preliminary Dan-NICAD II results to be presented at ESC

Press release Malmö, Sweden, August 23, 2021 Preliminary Dan-NICAD II results to be presented at ESC Acarix AB (publ) today ...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
23 Aug 2021

Preliminärt Dan-NICAD II-resultat presenteras på ESC

Press release Malmö, 23 augusti, 2021 Preliminärt Dan-NICAD II-resultat presenteras på ESC Acarix AB (publ) medd...
Continue reading
  • «
  • ‹
  • 21
  • 22
  • 23
  • 24
  • 25
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.